Navigation Links
New material could offer hope to those with no voice
Date:7/14/2011

to pursue a synthetic material because it would likely take less time to reach patients. "Making a totally natural vocal cord is a more long-term project," he says.

Other researchers have tried developing drugs that would dissolve the scar tissue, but the MIT/Harvard team decided on a different approach.

"What we did differently is we looked at this as a mechanical problem that we need to solve. We said, 'Let's not look at the scar itself as a problem, let's think of how we can improve the voice despite the presence of the scar tissue,'" says Karajanagi, who is now an instructor of surgery at Harvard Medical School and a researcher at the Center for Laryngeal Surgery and Voice Rehabilitation at Massachusetts General Hospital.

The team chose polyethylene glycol (PEG) as its starting material, in part because it is already used in many FDA-approved drugs and medical devices.

By altering the structure and linkage of PEG molecules, the researchers can control the material's viscoelasticity. In this case, they wanted to make a substance with the same viscoelasticity as human vocal cords. Viscoelasticity is critical to voice production because it allows the vocal cords to vibrate when air is expelled through the lungs.

For use in vocal cords, the researchers created and screened many variations of PEG and selected one with the right viscoelasticity, which they called PEG30. In laboratory tests, they showed that the vibration that results from blowing air on a vocal-fold model of PEG30 is very similar to that seen in human vocal folds. Also, tests showed that PEG30 can restore vibration to stiff, non-vibrating vocal folds such as those seen in human patients suffering from vocal-fold scarring.

Under FDA guidelines, the gel would be classified as an injectable medical device, rather than a drug. The researchers, who have published more than a dozen papers on their voice-restoration efforts, have applied for a patent on
'/>"/>

Contact: Marta Buczek
mbuczek@mit.edu
617-721-5749
Massachusetts Institute of Technology
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Stretching old material yields new results for energy- and environment-related devices
2. Materials scientist and entrepreneur Dr. John Rogers awarded $500,000 Lemelson-MIT Prize
3. Stevens conference explores latest innovations in antimicrobial biomaterials research
4. UH chemist investigates material for next-generation computer memory
5. The ultimate camo: Team to mimic camouflage skill of marine animals in high-tech materials
6. Researchers combine active proteins with material derived from fruit fly
7. NJIT professor develops a biologically inspired catalyst, an active yet inert material
8. Biomaterial banks for research -- clear strategies and recommendations needed
9. NC State develops material to remove radioactive contaminants from drinking water
10. Force of acoustical waves tapped for metamaterials
11. UCLA engineers demonstrate use of proteins as raw material for biofuels, biorefining
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2015)... NEW YORK , Feb. 24, 2015 This ... Thousands. The report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , ... America . Annual estimates and forecasts are provided for ... is provided for these markets. Market data and analytics are ...
(Date:2/23/2015)... Conn. , Feb. 23, 2015 NXT-ID, ... or the "Company"), a biometric authentication company focused on ... has filed provisional patent 62114357 for DISTRIBUTED ... this patent, NXT-ID introduces a new groundbreaking payment method. ... the payment account may only be accessed if both ...
(Date:2/13/2015)... 2015 ACT Genomics Co., Ltd., a ... transform cancer genomic information into precision diagnosis and ... raised US$ 8 million in the its first private ... Taipei, Taiwan , ACT Genomics has developed ... aim to implement next generation sequencing (NGS) and ...
Breaking Biology News(10 mins):World Iris Biometrics Industry 2World Iris Biometrics Industry 3World Iris Biometrics Industry 4World Iris Biometrics Industry 5World Iris Biometrics Industry 6World Iris Biometrics Industry 7World Iris Biometrics Industry 8World Iris Biometrics Industry 9World Iris Biometrics Industry 10World Iris Biometrics Industry 11NXT-ID Patents Voice Directed Payments 2NXT-ID Patents Voice Directed Payments 3ACT Genomics Raises $8 Million in its First Private Funding Round 2
... The Institute for Translational Medicine and Therapeutics, 7th ... Personalization and the Science of Scale, to be ... direct relevance to translational science. ITMAT is part ... University of Pennsylvania. , Speakers will include those ...
... a humane option for the control of feral and ... issued by the International Society of Feline Medicine (ISFM) ... published by SAGE. According to the society, which ... Care, culling to control cat populations is also rarely ...
... screening shellfish for fungal toxins is important, say scientists. ... Society for Applied Microbiology (SfAM) journal, Letters in ... contamination by strains of Penicillium fungus, bivalve ... at much higher levels that are found in the ...
Cached Biology News:Lab-on-a-chip tech, brain mapping & microbiome highlighted at translational med meeting 2ISFM takes a stand on welfare of unowned cats 2
(Date:3/3/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/rcv4lq/gene_therapy ... Therapy Market, 2015 - 2025" report to their ... report provides an extensive study on the marketed and ... carried out in this field for over a decade ... in Asian markets; one approved in the EU). There ...
(Date:3/3/2015)... California (PRWEB) March 03, 2015 Crown ... service company, has launched a new Life Science division ... for preclinical research. , The first products released ... isotype controls, and soon to be released in vivo ... will continue to expand their life science portfolio with ...
(Date:3/3/2015)... March 3, 2015  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ... scientific journal, Expert Opinion on Biological Therapy , ... Zhenggang Zhang , at the Henry Ford Hospital ... Thymosin beta 4 (TB4) has the capacity to promote ... or more post-injury, leading to neurological recovery in each ...
(Date:3/3/2015)... Liberty Corner, New Jersey (PRWEB) March 03, 2015 ... in NJ, has announced today that it has ... DE. Terms of the transaction were not ... engineering consulting services to the energy sector including ... gas, alternative energy, and fossil and nuclear power ...
Breaking Biology Technology:Global Gene Therapy Market Report 2015-2025 - Extensive Study on the Marketed and Pipeline Gene Therapies 2Global Gene Therapy Market Report 2015-2025 - Extensive Study on the Marketed and Pipeline Gene Therapies 3Global Gene Therapy Market Report 2015-2025 - Extensive Study on the Marketed and Pipeline Gene Therapies 4Global Gene Therapy Market Report 2015-2025 - Extensive Study on the Marketed and Pipeline Gene Therapies 5Global Gene Therapy Market Report 2015-2025 - Extensive Study on the Marketed and Pipeline Gene Therapies 6Global Gene Therapy Market Report 2015-2025 - Extensive Study on the Marketed and Pipeline Gene Therapies 7Crown Bioscience Launches Life Science Product Catalog 2Researchers at Henry Ford Hospital Propose Thymosin Beta 4 as Novel Way to Treat Neural Injury and Neurodegenerative Diseases 2Researchers at Henry Ford Hospital Propose Thymosin Beta 4 as Novel Way to Treat Neural Injury and Neurodegenerative Diseases 3
... in Quality by Design Initiative for Protein Therapeutics - ... Sciences, Inc. (Nasdaq: CALP ), a leading ... life sciences research, today launched the Staccato Protein Workstation ... therapeutics and biogenerics. , , With a ...
... Md., June 29 Micromet, Inc. (Nasdaq: ... for the treatment of cancer, inflammation and autoimmune diseases, ... 3000 Index as part of the annual reconstitution of ... , , "Investors recognize the Russell 3000 as ...
... ever involving patients with cutaneous T-cell lymphoma on schedule ... RADNOR, Pa., June 29 Yaupon Therapeutics, a privately ... enrollment for a pivotal Phase 2 clinical trial for ... (CTCL - stages 1-2a). The study, which is ...
Cached Biology Technology:Caliper Life Sciences Introduces Staccato Protein Workstation for Automated Protein Sample Preparation & Analysis 2Caliper Life Sciences Introduces Staccato Protein Workstation for Automated Protein Sample Preparation & Analysis 3Micromet Added to Russell 3000 Index 2Micromet Added to Russell 3000 Index 3Micromet Added to Russell 3000 Index 4Yaupon Therapeutics Completes Patient Enrollment for Pivotal Phase 2 Study of Clearazide for Treatment of Cutaneous T-cell Lymphoma 2